Medicare Compliance & Reimbursement - 2003 Issue 11
Drugs: Jan. 1 Could Be D-Day for Drug Payments
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare payment policy issue involving drug reimbursement methodology, the timing of possible CMS changes, and related congressional activity. It is relevant to physicians who dispense medications under Medicare, oncology and other specialties that administer drugs, and coding/billing professionals tracking payment updates, fee schedule changes, and advocacy efforts. The discussion focuses on general reimbursement policy, CMS rulemaking timing, and legislative proposals tied to drug and practice expense payments.
Why This Topic Matters
The piece highlights a potential near-term Medicare payment change that could affect physician reimbursement, practice expenses, and planning for drug administration services.
What You Will Learn
- How Medicare drug payment policy timing may affect physician reimbursement
- Why CMS rulemaking deadlines matter for drug and practice expense payments
- Which specialties are most likely to be affected by payment changes
- How congressional and advocacy actions may influence reimbursement reform
Who Should Read This
- Oncologists
- Physicians who dispense medications under Medicare
- Medical practice managers
- Coding and billing professionals
- Healthcare reimbursement analysts
- Policy and compliance staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com